BioSpace News Archive

Deals

Exact Sciences to participate in May investor conferences

Exact Sciences Corp. announced that company management will be presenting at the following investor conferences and invited investors to participate by webcast.

May 1, 2019
·
4 min read
BioForest

Survey: Americans Becoming More Open About Mental Health

American adults mostly harbor positive views about mental health, though some stigma remains.

May 1, 2019
·
4 min read
Deals

United Therapeutics Corporation Reports First Quarter 2019 Financial Results

United Therapeutics Corporation announced its financial results for the quarter ended March 31, 2019.

May 1, 2019
·
13 min read
Job Trends

Survey reveals hearing loss can significantly affect relationships and families in the U.S.

State of Hearing Report highlights the physical, emotional and societal challenges of hearing loss

May 1, 2019
·
5 min read
Canada’s Newly Certified Medical Specialists Struggle to Find Work

A study based on a multi-year survey of 6,200 specialists released by the Royal College of Physicians and Surgeons of Canada revealed the highest percentage of reported employment challenges since the launch of the Royal College Employment Survey in 2011.

May 1, 2019
·
3 min read
BioCapital

MaxCyte Presents at 22nd Annual ASGCT Meeting on Manufacturing Process for First CARMA™ Drug Candidate, Including One-Day Cell Processing

CARMA drug candidates can be manufactured via streamlined, single-day process, providing a much needed faster turnaround of autologous cell therapy to patients

May 1, 2019
·
3 min read
Business

Variant Pharmaceuticals Has a New Name - ZyVersa Therapeutics, Inc.

Reflects the versatility required to be on the forefront of innovation to meet unmet medical needs

May 1, 2019
·
1 min read
Biotech Beach

Positive clinical data at AAN 2019 reinforces Ionis’ commitment to delivering life-changing medicines to patients with neurological diseases

Twelve presentations highlighting transformational medicines for SMA, hATTR, Huntington’s disease, ALS, prion disease and others

May 1, 2019
·
7 min read
Policy

Triumvira Submits Investigational New Drug (IND) Application to the FDA and Clinical Trial Application (CTA) to Health Canada to Evaluate TAC01-CD19, a T Cell Antigen Coupler Therapy, in Ph 1/2 TACTIC-19 Trial

Triumvira Immunologics Inc. has simultaneously submitted an IND to the U.S. Food and Drug Administration and a CTA to Health Canada to initiate a Phase 1/2, first-in-human trial of TAC01-CD19, a TAC-T cell therapy product engineered to target CD-19 in patients with Relapsed/Refractory Large B-Cell Lymphoma.

May 1, 2019
·
3 min read
Pharm Country

G.research’s 11th Annual Entertainment & Broadcasting Conference

G.research will host its 11th Annual Entertainment & Broadcasting Conference on June 6 in New York City.

May 1, 2019
·
1 min read